Jeffrey E. Russel

Array ( [id] => 7237570 [patent_doc_number] => 20050080011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Stabilization of pharmaceutical protein formulations with small peptides' [patent_app_type] => utility [patent_app_number] => 10/683549 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7455 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080011.pdf [firstpage_image] =>[orig_patent_app_number] => 10683549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7452835 [patent_doc_number] => 20040067886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Use of inhibitors of protein kinase C epsilon to treat pain' [patent_app_type] => new [patent_app_number] => 10/677426 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11025 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067886.pdf [firstpage_image] =>[orig_patent_app_number] => 10677426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968671 [patent_doc_number] => 06939946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Ring modified cyclic peptide analogs' [patent_app_type] => utility [patent_app_number] => 10/676575 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939946.pdf [firstpage_image] =>[orig_patent_app_number] => 10676575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531205 [patent_doc_number] => 07175828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Modulators of β-amyloid peptide aggregation comprising D-amino acids' [patent_app_type] => utility [patent_app_number] => 10/677076 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25135 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/175/07175828.pdf [firstpage_image] =>[orig_patent_app_number] => 10677076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051275 [patent_doc_number] => 20050187162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Novel peptide with osteogenic activity' [patent_app_type] => utility [patent_app_number] => 10/674516 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10834 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187162.pdf [firstpage_image] =>[orig_patent_app_number] => 10674516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 759991 [patent_doc_number] => 07011825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Erythropoietin solution preparation' [patent_app_type] => utility [patent_app_number] => 10/674446 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3317 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/011/07011825.pdf [firstpage_image] =>[orig_patent_app_number] => 10674446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674706 [patent_doc_number] => 20040127412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Modified GLP-1 peptides with increased biological potency' [patent_app_type] => new [patent_app_number] => 10/671340 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7038 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127412.pdf [firstpage_image] =>[orig_patent_app_number] => 10671340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1022033 [patent_doc_number] => 06887976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 10/669778 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23168 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887976.pdf [firstpage_image] =>[orig_patent_app_number] => 10669778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473779 [patent_doc_number] => 20040121959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Peptides and related molecules that modulate nerve growth factor activity' [patent_app_type] => new [patent_app_number] => 10/666480 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24688 [patent_no_of_claims] => 163 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121959.pdf [firstpage_image] =>[orig_patent_app_number] => 10666480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034178 [patent_doc_number] => 20050032688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Use of angiotensin II fragments and analogs thereof in tissue repair' [patent_app_type] => utility [patent_app_number] => 10/667066 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7578 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032688.pdf [firstpage_image] =>[orig_patent_app_number] => 10667066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892157 [patent_doc_number] => 07345022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Anti-fibril peptides' [patent_app_type] => utility [patent_app_number] => 10/666095 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10807 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345022.pdf [firstpage_image] =>[orig_patent_app_number] => 10666095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304437 [patent_doc_number] => 20040115785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Protein purification' [patent_app_type] => new [patent_app_number] => 10/663483 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8209 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115785.pdf [firstpage_image] =>[orig_patent_app_number] => 10663483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972262 [patent_doc_number] => 20050037972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Phage-display peptides as novel antimicrobial agents against haemophilus influenzae' [patent_app_type] => utility [patent_app_number] => 10/655562 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10103 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037972.pdf [firstpage_image] =>[orig_patent_app_number] => 10655562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612800 [patent_doc_number] => 07148197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Orally administered small peptides synergize statin activity' [patent_app_type] => utility [patent_app_number] => 10/649378 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 34255 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148197.pdf [firstpage_image] =>[orig_patent_app_number] => 10649378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914506 [patent_doc_number] => 07326686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Compounds and methods for regulating cell adhesion' [patent_app_type] => utility [patent_app_number] => 10/648854 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 32 [patent_no_of_words] => 29620 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326686.pdf [firstpage_image] =>[orig_patent_app_number] => 10648854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397372 [patent_doc_number] => 20040038898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation' [patent_app_type] => new [patent_app_number] => 10/646493 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12572 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038898.pdf [firstpage_image] =>[orig_patent_app_number] => 10646493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380191 [patent_doc_number] => 20040081659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/641667 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11653 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081659.pdf [firstpage_image] =>[orig_patent_app_number] => 10641667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707859 [patent_doc_number] => 07060678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Peptides comprising furanoid sugar amino acids for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/638107 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9886 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060678.pdf [firstpage_image] =>[orig_patent_app_number] => 10638107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463924 [patent_doc_number] => 20040101552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Pharmaceutical compositions' [patent_app_type] => new [patent_app_number] => 10/632951 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3011 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101552.pdf [firstpage_image] =>[orig_patent_app_number] => 10632951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314184 [patent_doc_number] => 20040033946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Cell damage inhibitor' [patent_app_type] => new [patent_app_number] => 10/399044 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2630 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033946.pdf [firstpage_image] =>[orig_patent_app_number] => 10399044 [rel_patent_id] =>[rel_patent_doc_number] =>)